We named this phenomenon as “NAMPT resistance.” Additionally, our study revealed that obesity decreased SIRT1 levels, which leads to increased NAMPT acetylation level and decreased NAD+/NADH ratio. The gene discussed is NAMPT; the disease is obesity disorder.